Mental Health Literacy and Academic Performance
Launched by UNIVERSITY OF BUCHAREST · Jan 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving mental health understanding and academic performance among high school students, especially those who may face extra challenges. The researchers want to find out if a special program can help students learn more about mental health, support their well-being, and boost their school performance. Participants will be divided into two groups: one will receive online educational materials about mental health, while the other will get the same materials plus live sessions with a licensed psychologist. There’s also a third group that will not receive any treatment right away, which will help the researchers compare the results.
If you're a high school student aged 14 to 18, you could be eligible to join this study. By participating, you can expect to learn useful information about mental health in a way that fits your schedule. The trial is currently looking for participants, and your involvement could make a difference not only for yourself but also for other students facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in High School
- Exclusion Criteria:
- • Younger than 14 or older than 18
About University Of Bucharest
The University of Bucharest, a prestigious institution of higher education and research in Romania, serves as a prominent clinical trial sponsor dedicated to advancing scientific knowledge and improving public health outcomes. With a robust framework for research and innovation, the university fosters interdisciplinary collaboration among leading experts in various fields, including medicine, pharmacology, and social sciences. Through its commitment to ethical research practices and rigorous scientific standards, the University of Bucharest aims to contribute valuable insights and evidence-based solutions to contemporary healthcare challenges, while ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bucharest, , Romania
Patients applied
Trial Officials
Cezar Giosan, PhD
Principal Investigator
University of Bucharest
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported